Join the PharmaShots Family of 20000+ Subscribers by PharmaShots

PharmaShots Dec 3, 2025

Evorpacept’s Momentum in HER2+ Gastric Cancer: A Conversation with Jason Lettmann from ALX Oncology 

Shots: Saurabh: Could you provide a brief summary of your CD47 therapy, evorpacept, and what distinguishes it from…

Read article →
PharmaShots Dec 3, 2025

Formosa Pharmaceuticals Collaborates with Rxilient to Commercialize APP13007 Across ASEAN Markets

Shots: Ref: PRNewswire | Image: Formosa & Rxilient | Press Release Related News: Formosa Pharmaceuticals Receives the US…

Read article →
PharmaShots Dec 3, 2025

Imvax Reports P-IIb Trial Findings on IGV-001 to Treat Newly Diagnosed Glioblastoma

Shots: Ref: Businesswire | Image: Imvax | Press Release Related News: Belite Bio Reports Topline P-III (DRAGON) Trial…

Read article →
PharmaShots Dec 3, 2025

Ionis’ Zilganersen Receives the US FDA’s Breakthrough Therapy Designation for Alexander Disease

Shots: Ref: Ionis | Image: Ionis | Press Release Related News: The CHMP Recommends Ionis and Otsuka’s Dawnzera…

Read article →
PharmaShots Dec 3, 2025

Francis Medical’s Vanquish Water Vapor System Receives the US FDA 510(k) Clearance for Prostate Tissue Ablation

Shots: Ref: Francis Medical | Image: Francis Medical | Press Release Related News: Roche’s Point-of-Care PCR Test…

Read article →
PharmaShots Dec 3, 2025

The US FDA Approves Additional Presentation of Celltrion’s Omlyclo (Biosimilar, Xolair)

Shots: Ref: PRNewswire | Image: Celltrion | Press Release Related News: Celltrion’s Eydenzelt (Biosimilar, Eylea)…

Read article →
PharmaShots Dec 3, 2025

AstraZeneca Reports the US FDA’s NDA Acceptance with Priority Review of Baxdrostat for Hard-to-Control Hypertension

Shots: Ref: AstraZeneca | Image: AstraZeneca | Press Release Related News: AstraZeneca Secures the US FDA Approval of…

Read article →
PharmaShots Dec 2, 2025

Key Biosimilars Events of October 2025  

Shots: Company: Alvotech Product: AVT05 Active Ingredient: Golimumab Reference Product: Simponi Reference Product…

Read article →